Literature DB >> 13680109

A 7-year study of severe hospital-acquired pneumonia requiring ICU admission.

Jordi Vallés1, Eduard Mesalles, Dolors Mariscal, Ma del Mar Fernández, Rocío Peña, José Luis Jiménez, Jordi Rello.   

Abstract

OBJECTIVE: To examine the characteristics, prognostic factors, and outcome of patients with severe hospital-acquired pneumonia admitted to the ICU. DESIGN AND
SETTING: Prospective observational clinical study in two medical-surgical ICUs with 16 and 20 beds PATIENTS AND PARTICIPANTS: During a 7-year period all hospitalized patients requiring admission to either ICU for hospital-acquired pneumonia were followed up. MEASUREMENTS AND
RESULTS: We diagnosed 96 episodes of severe hospital-acquired pneumonia, and in 67 cases a causal diagnosis was made. Most episodes were late-onset pneumonia. Gram-negative micro-organisms were isolated in 51% of episodes diagnosed, and Pseudomonas aeruginosa was the most frequent pathogen isolated (24%). Clearly significant variations happened between hospitals, particularly affecting the incidence of Aspergillus spp. and Legionella pneumophila. Forty-nine patients developed septic shock (51%). Fifty-one patients died (53%). Aspergillosis and pneumonia due to P. aeruginosa were associated with the highest mortality. Septic shock (OR: 14.27) and chronic obstructive pulmonary disease (OR: 6.11) were independently associated with a poor prognosis.
CONCLUSIONS: Patients with severe hospital-acquired pneumonia admitted to the ICU present high mortality. The presence of septic shock and chronic obstructive pulmonary disease in conjunction with specific microorganisms are associated with a poor prognosis. Local epidemiological data combined with a patient-based approach may allow a more accurate therapy decision making.

Entities:  

Mesh:

Year:  2003        PMID: 13680109     DOI: 10.1007/s00134-003-2008-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  47 in total

1.  Rapidly progressive respiratory failure due to Aspergillus pneumonia: a complication of short-term corticosteroid therapy.

Authors:  J M Crean; M S Niederman; A M Fein; S H Feinsilver
Journal:  Crit Care Med       Date:  1992-01       Impact factor: 7.598

2.  Impact of management guidelines on the outcome of severe community acquired pneumonia.

Authors:  N A Hirani; J T Macfarlane
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

Review 3.  Nosocomial pneumonia. Diagnosis and prevention.

Authors:  C G Mayhall
Journal:  Infect Dis Clin North Am       Date:  1997-06       Impact factor: 5.982

4.  Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa.

Authors:  J Rello; P Jubert; J Vallés; A Artigas; M Rué; M S Niederman
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 6.  Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R LeGall; A Morris; R Spragg
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

7.  Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC).

Authors:  J Vallés; C León; F Alvarez-Lerma
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

8.  Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques.

Authors:  J Y Fagon; J Chastre; Y Domart; J L Trouillet; J Pierre; C Darne; C Gibert
Journal:  Am Rev Respir Dis       Date:  1989-04

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit.

Authors:  O Leroy; C Santré; C Beuscart; H Georges; B Guery; J M Jacquier; G Beaucaire
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

View more
  16 in total

Review 1.  Year in review in Intensive Care Medicine-2003. Part 1: Respiratory failure, infection and sepsis.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoît Vallet
Journal:  Intensive Care Med       Date:  2004-05-15       Impact factor: 17.440

2.  Gamma interferon does not enhance clearance of Pseudomonas aeruginosa but does amplify a proinflammatory response in a murine model of postseptic immunosuppression.

Authors:  E D Murphey; David N Herndon; Edward R Sherwood
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

3.  Should electronic faucets be used in intensive care and hematology units?

Authors:  Jacques Merrer; Emmanuelle Girou; David Ducellier; Nicole Clavreul; Florence Cizeau; Patrick Legrand; Michel Leneveu
Journal:  Intensive Care Med       Date:  2005-10-15       Impact factor: 17.440

4.  Infections of respiratory or abdominal origin in ICU patients: what are the differences?

Authors:  Elena Volakli; Claudia Spies; Argyris Michalopoulos; A B Johan Groeneveld; Yasser Sakr; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

5.  Incidence of pulmonary aspergillosis and correlation of conventional diagnostic methods with nested PCR and real-time PCR assay using BAL fluid in intensive care unit patients.

Authors:  Hossein Zarrinfar; Koichi Makimura; Kazuo Satoh; Hossein Khodadadi; Hossein Mirhendi
Journal:  J Clin Lab Anal       Date:  2013-05       Impact factor: 2.352

6.  The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit.

Authors:  Chih-Yen Tu; Wu-Huei Hsu; Te-Chun Hsia; Hung-Jen Chen; Kuo-Liang Chiu; Liang-Wen Hang; Chuen-Ming Shih
Journal:  Intensive Care Med       Date:  2006-02-15       Impact factor: 17.440

Review 7.  Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia.

Authors:  Jordi Rello
Journal:  Crit Care       Date:  2004-11-30       Impact factor: 9.097

Review 8.  Pseudomonas aeruginosa ventilator-associated pneumonia management.

Authors:  Sergio Ramírez-Estrada; Bárbara Borgatta; Jordi Rello
Journal:  Infect Drug Resist       Date:  2016-01-20       Impact factor: 4.003

9.  Analysis of adherence to national nosocomial pneumonia treatment guidelines.

Authors:  Edward H Eiland; Kurt A Wargo; Wayne Hamm; Ali Am Hassoun
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

Review 10.  How to manage aspergillosis in non-neutropenic intensive care unit patients.

Authors:  Matteo Bassetti; Elda Righi; Gennaro De Pascale; Raffaele De Gaudio; Antonino Giarratano; Tereesita Mazzei; Giulia Morace; Nicola Petrosillo; Stefania Stefani; Massimo Antonelli
Journal:  Crit Care       Date:  2014-07-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.